Related Experiment Video
Updated: Dec 27, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Kawasaki Disease in Children Older Than 10 Years: A Clinical Experience From Northwest India
Ankur Kumar Jindal1, Rakesh Kumar Pilania1, Sandesh Guleria1
1Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Insights
Diagnosing Kawasaki disease (KD) in older children is often delayed, increasing their risk for coronary artery abnormalities (CAAs). This study highlights the challenges and outcomes in patients aged 10 and above.
Area of Science:
- Pediatrics
- Cardiology
- Rheumatology
Background:
- Kawasaki disease (KD) primarily affects children under 5.
- Delayed diagnosis in older children (≥10 years) elevates the risk of coronary artery abnormalities (CAAs).
- Limited research exists on KD presentation and outcomes in older pediatric populations.
Purpose of the Study:
- To investigate the characteristics of Kawasaki disease in patients aged 10 years and older.
- To assess the diagnostic delay and associated risks, particularly CAAs, in this understudied group.
Main Methods:
- Retrospective review of medical records for patients diagnosed with KD aged ≥10 years.
- Data collected from January 1994 to June 2019.
- Analysis of clinical presentation, diagnostic intervals, treatment, and outcomes, including CAAs.
Main Results:
- 46 patients (5.3%) aged ≥10 years were diagnosed with KD, with a median age of 11 years.
- Median delay between fever onset and diagnosis was 12 days.
- Coronary artery abnormalities (CAAs) occurred in 13.04% of older patients; 17.4% presented with hypotensive shock.
Conclusions:
- Delayed diagnosis is common in older children with Kawasaki disease.
- Patients aged 10 and above diagnosed with KD face a heightened risk of developing CAAs.
- Early recognition and treatment are crucial to mitigate severe cardiovascular complications.
Abstract:
Background: Kawasaki disease (KD) is predominantly seen in young children (<5 years). Diagnosis of KD is often delayed in older children and adolescents, leading to a higher risk of coronary artery abnormalities (CAAs). There is a paucity of literature on KD in older children. Methods: Data were collated from a review of records of patients diagnosed with KD who were aged ≥10 years at the time of diagnosis, during the period from January 1994 to June 2019. Results: Eight hundred and sixty five patients were diagnosed with KD during this period. Of these, 46 (5.3%; 26 boys and 20 girls) were aged 10 years or older at the time of diagnosis. The median age at diagnosis was 11 years (range of 10-30 years). The median interval between the of fever and the diagnosis of KD was 12 days (range of 4-30 days). Eight patients (17.4%) presented with hypotensive shock. Coronary artery abnormalities (CAAs) were seen in six patients (13.04%), and three patients had myocarditis. Patients with CAAs were found to have significantly higher median platelet counts and higher median C-reactive protein levels. First-line treatment included intravenous immunoglobulin. Adjunctive therapy was given in five patients (infliximab in four patients and steroids in one patient). The median time between the onset of fever and the administration of IVIg was 13.5 days (range of 6-2). The total duration of follow up is 2,014.5 patient-months. Conclusion: Diagnosis of KD in children older than 10 years is usually delayed, and these patients are thus at a higher risk of CAAs.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease I: Introduction
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Myocarditis II: Clinical Features and Diagnostic Tests
